Marcusa DP, Mann RA, Cron DC, et al. Prescription opioid use among opioid-naive women undergoing immediate breast reconstruction. Plast Reconstr Surg. 2017;140(6):1081–1090.
Hart AM, Broecker JS, Kao L, Losken A. Opioid use following outpatient breast surgery: are physicians part of the problem? Plast Reconstr Surg. 2018; 142(3):611–620.
Olds C, Spataro E, Li K, Kandathil C, Most SP. Assessment of persistent and prolonged postoperative opioid use among patients undergoing plastic and reconstructive surgery. JAMA Facial Plast Surg. 2019;21(4):286–291.
Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL. Prescription opioid analgesics commonly unused after surgery: a systematic review. JAMA Surg. 2017;152(11):1066–1071.
Hill MV, McMahon ML, Stucke RS, Barth RJ. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg. 2017;265(4):709–714.
Rose KR, Christie BM, Block LM, Rao VK, Michelotti BF. Opioid prescribing and consumption patterns following outpatient plastic surgery procedures. Plast Reconstr Surg. 2019;143(3):929–938.
Fan B, Valente SA, Shilad S, et al. Reducing narcotic prescriptions in breast surgery: a prospective analysis. Ann Surg Oncol. 2019;26(10):3109–3114.
Rothenberg KA, Huyser MR, Edquilang JK, et al. Experience with a nonopioid protocol in ambulatory breast surgery: opioids are rarely necessary and use is surgeon-dependent. Perm J. 2019;23:18–127.
Opioids for acute pain: what you need to know. U.S. Department of Health and Human Services. https://www.cdc.gov/drugoverdose/pdf/patients/Opioids-for-Acute-Pain-a.pdf. Accessed Aug 8, 2019.
Kahlenberg CA, Stepan JG, Premkumar A, Lovecchio FD, Cross MB. Institutional guidelines can decrease the amount of opioids prescribed after total joint replacement. HSS J. 2019;15(1):27–30.
Stepan JG, Lovecchio FC, Premkumar A, et al. Development of an institutional opioid prescriber education program and opioid-prescribing guidelines: impact on prescribing practices. J Bone Joint Surg Am. 2019;101(1):5-13.
Hartford LB, Van Koughnett JAM, Murphy PB, et al. Standardization of outpatient procedure (STOP) narcotics: a prospective non-inferiority study to reduce opioid use in outpatient general surgical procedures. J Am Coll Surg. 2019;228(1):81–88.e81.
Hartford LB, Van Koughnett JAM, Murphy PB, et al. The standardization of outpatient procedure (STOP) narcotics: a prospective health systems intervention to reduce opioid use in ambulatory breast surgery. Ann Surg Oncol. 2019;26(10):3295–3304.
Moride Y, Lemieux-Uresandi D, Castillon G, et al. A systematic review of interventions and programs targeting appropriate prescribing of opioids. Pain Physician. 2019;22(3):229–240.
McGugin CJ, Coopey SB, Smith BL, et al. Enhanced recovery minimizes opioid use and hospital stay for patients undergoing mastectomy with reconstruction. Ann Surg Oncol. 2019;26(11):3464–3471.
Dumestre DO, Webb CE, Temple-Oberle C. Improved recovery experience achieved for women undergoing implant-based breast reconstruction using an enhanced recovery after surgery model. Plast Reconstr Surg. 2017;139(3):550–559.
Chiu C, Aleshi P, Esserman LJ, et al. Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy. BMC Anesthesiol. 2018;18(1):41.
Subramanian B, Shastri N, Aziz L, et al. ASSIST—patient satisfaction survey in postoperative pain management from Indian subcontinent. J Anaesthesiol Clin Pharmacol. 2017;33(1):40–47.
Temple-Oberle C, Shea-Budgell MA, Tan M, et al. Consensus review of optimal perioperative care in breast reconstruction: Enhanced Recovery after Surgery (ERAS) Society recommendations. Plast Reconstr Surg. 2017;139(5):1056e–1071e.
Sato F, Arinaga Y, Sato N, Ishida T, Ohuchi N. The perioperative educational program for improving upper arm dysfunction in patients with breast cancer at 1-year follow-up: a prospective, controlled trial. Tohoku J Exp Med. 2016;238(3):229–236.
Bennett MI, Bagnall AM, José Closs S. How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. Pain. 2009;143(3):192–199.
Ling CC, Lui LY, So WK. Do educational interventions improve cancer patients’ quality of life and reduce pain intensity? Quantitative systematic review. J Adv Nurs. 2012;68(3):511–520.
Darnall BD, Ziadni MS, Krishnamurthy P, et al. “My surgical success”: effect of a digital behavioral pain medicine intervention on time to opioid cessation after breast cancer surgery—a pilot randomized controlled clinical trial. Pain Med. 2019:20(11):2228–2237.
Opioid morphine equivalent conversion factors. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Opioid/Morphine-EQ-Conversion-Factors-March-2015.pdf. Accessed May 6, 2019.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
De Groef A, Devoogdt N, Van der Gucht E, et al. EduCan trial: study protocol for a randomised controlled trial on the effectiveness of pain neuroscience education after breast cancer surgery on pain, physical, emotional and work-related functioning. BMJ Open. 2019;9(1):e025742.
Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790.
Egan KG, De Souza M, Muenks E, Nazir N, Korentager R. Predictors of opioid consumption in immediate, implant-based breast reconstruction. Plast Reconstr Surg. 2020 (in press).